EUVIMEDEUVIMED entdecken
Crossref

Anti-coronavirus and anti-pulmonary inflammation effects of iridoids, the common component from Chinese herbal medicines for the treatment of COVID-19

Dan-Yu Huang, Yong-Xin Luo, Wen-De Zheng, Shu-Yu Wu, Pei-Qi Huang, Jing-Wei Jin, Pan-Pan Wu, Li-She Gan

Journal of Natural Medicines · 2024

DOI: 10.1007/s11418-024-01820-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Natural Medicines, 2024. Verfasst von Dan-Yu Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, 260 Baichuan St, Hangzhou, 311402, People's Republic of China. Hauptthemen laut MEDLINE: Iridoids, Antiviral Agents, Drugs, Chinese Herbal, SARS-CoV-2. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: Department of Education of Guangdong Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The practice of Chinese herbal medicines for the treatment of COVID-19 in China played an essential role for the control of mortality rate and reduction of recovery time. The iridoids is one of the main constituents of many heat-clearing and detoxifying Chinese medicines that were largely planted and frequently used in clinical practice. Twenty-three representative high content iridoids from several staple Chinese medicines were obtained and tested by a SARS-CoV-2 pseudo-virus entry-inhibition assay on HEK-293 T/ACE2 cells, a live HCoV-OC43 virus infection assay on HRT-18 cells, and a SARS-CoV-2 3CL protease inhibitory FRET assay followed by molecular docking simulation. The anti-pulmonary inflammation activities were further evaluated on a TNF-α induced inflammation model in A549 cells and preliminary SARs were concluded. The results showed that specnuezhenide (7), cornuside (12), neonuezhenide (15), and picroside III (21) exhibited promising antiviral activities, and neonuezhenide (15) could inhibit 3CL protease with an IC50 of 14.3 μM. Docking computation showed that compound 15 could bind to 3CL protease through a variety of hydrogen bonding and hydrophobic interactions. In the anti-pulmonary inflammation test, cornuside (12), aucubin (16), monotropein (17), and shanzhiside methyl ester (18) could strongly decrease the content of IL-1β and IL-8 at 10 μM. Compound 17 could also upregulate the expression of the anti-inflammatory cytokine IL-10 significantly. The iridoids exhibited both anti-coronavirus and anti-pulmonary inflammation activities for their significance of existence in Chinese herbal medicines, which also provided a theoretical basis for their potential utilization in the pharmaceutical and food industries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IridoidsAntiviral AgentsDrugs, Chinese HerbalSARS-CoV-2COVID-19 Drug TreatmentMolecular Docking SimulationHumansA549 CellsHEK293 CellsCOVID-19Coronavirus 3C ProteasesAnti-Inflammatory AgentsCoronavirus OC43, Human

Stichwörter der Autor:innen

Anti-coronavirusesAnti-pulmonary inflammationChinese herbal medicineIridoidsStructure–activity relationship

Substanzen

IridoidsAntiviral AgentsDrugs, Chinese HerbalCoronavirus 3C ProteasesAnti-Inflammatory Agents

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, 260 Baichuan St, Hangzhou, 311402, People's Republic of China.
  • School of Pharmacy and Food Engineering, International Healthcare Innovation Institute, Wuyi University, 99 Yingbin Ave, 529020, Jiangmen, People's Republic of China.
  • School of Pharmacy and Food Engineering, International Healthcare Innovation Institute, Wuyi University, 99 Yingbin Ave, 529020, Jiangmen, People's Republic of China. wyuchemwpp@126.com.
  • School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, 260 Baichuan St, Hangzhou, 311402, People's Republic of China. lsgan@zcmu.edu.cn.
  • School of Pharmacy and Food Engineering, International Healthcare Innovation Institute, Wuyi University, 99 Yingbin Ave, 529020, Jiangmen, People's Republic of China. lsgan@zcmu.edu.cn.

Förderung

  • Department of Education of Guangdong Province
  • National Natural Science Foundation of China

Zitieren

APA

Huang, D. Y., Luo, Y. X., Zheng, W. D., Wu, S. Y., Huang, P. Q., Jin, J. W., Wu, P. P., & Gan, L. S. (2024). Anti-coronavirus and anti-pulmonary inflammation effects of iridoids, the common component from Chinese herbal medicines for the treatment of COVID-19. Journal of Natural Medicines. https://doi.org/10.1007/s11418-024-01820-3

Vancouver

Huang DY, Luo YX, Zheng WD, Wu SY, Huang PQ, Jin JW, et al. Anti-coronavirus and anti-pulmonary inflammation effects of iridoids, the common component from Chinese herbal medicines for the treatment of COVID-19. Journal of Natural Medicines. 2024. doi:10.1007/s11418-024-01820-3

BibTeX
@article{Huang2024,
  author = {Huang, Dan-Yu and Luo, Yong-Xin and Zheng, Wen-De and Wu, Shu-Yu and Huang, Pei-Qi and Jin, Jing-Wei and Wu, Pan-Pan and Gan, Li-She},
  title = {Anti-coronavirus and anti-pulmonary inflammation effects of iridoids, the common component from Chinese herbal medicines for the treatment of COVID-19},
  journal = {Journal of Natural Medicines},
  year = {2024},
  doi = {10.1007/s11418-024-01820-3}
}
Kostenlos starten →